TCM
ENZ

Teza Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Teza Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-14,636
Closed -$102K – 607
2016
Q4 		$102K Buy
+14,636
New +$93.4K 0.14% 206

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teza Capital Management's ENZ Position: Q1 2017 in Review

Teza Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2017, closing a stake of 14,636 shares — an estimated $102K sold.

Teza Capital Management first reported a position in ENZ in Q4 2016 and held it in 1 quarter. The position peaked at $102K in Q4 2016. 109 funds tracked by Wall St. Rank hold ENZ as of Q1 2017.

  • Teza Capital Management reported no remaining Enzo Biochem, Inc. position as of Q1 2017 after selling out during the quarter.
  • Teza Capital Management sold 14,636 Enzo Biochem, Inc. shares in Q1 2017, an estimated $102K.
  • Teza Capital Management first reported a position in Enzo Biochem, Inc. in Q4 2016 and held it in 1 quarter.
  • Teza Capital Management's Enzo Biochem, Inc. position peaked at $102K in Q4 2016.
  • 109 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2017.

Based on Teza Capital Management's 13F filing for Q1 2017, filed 4 May 2017.